WEX Pharmaceuticals Inc. is a late-stage drug development company in Vancouver, Canada dedicated to the research, development, manufacture, and commercialization of Halneuron®, a new novel non-opioid analgesic. Halneuron® is a highly selective sodium channel blocker and represents a breakthrough in painkiller technology: - Non-addictive, no withdrawal symptoms and no euphoria - No build of up of tolerance over time - A long duration of pain relief with minimal side effects - Safe for human use and tested in over 700 people to date Halneuron® is entering into Phase III clinical trials for chemotherapy-induced neuropathic pain and concurrently being tested in other pain indications.
View Top Employees from WEX Pharmaceuticals Inc.Website | http://www.wexpharma.com |
Revenue | $7.7 million |
Employees | 10 (6 on RocketReach) |
Founded | 1987 |
Address | 1100 Melville St, 1150, Vancouver, British Columbia V6E 4A6, CA |
Phone | (604) 683-8880 |
Fax | (604) 683-8868 |
Technologies |
JavaScript,
HTML,
PHP
+8 more
(view full list)
|
Industry | Biotechnology Research, Drug Stores & Pharmacies, Retail |
Competitors | Autoimmune Inc, Cara Therapeutics, DelSiTech Ltd, Napp Pharmaceuticals Limited, Vapogenix, Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular WEX Pharmaceuticals Inc. employee's phone or email?
The WEX Pharmaceuticals Inc. annual revenue was $7.7 million in 2024.
Abner Yong is the CFO of WEX Pharmaceuticals Inc..
6 people are employed at WEX Pharmaceuticals Inc..
WEX Pharmaceuticals Inc. is based in Vancouver, British Columbia.
The NAICS codes for WEX Pharmaceuticals Inc. are [325, 3254, 32, 32541].
The SIC codes for WEX Pharmaceuticals Inc. are [283, 28].